NVIV

InVivo Therapeutics Holdings Corporation
2.38
0.05 (2.15%)
Upgrade to Real-Time
Regular Market
2.38
Volume 57,457
Bid Price 2.31
Ask Price 2.36
News -
Day High 2.41

Low
0.1953

52 Week Range

High
13.7699

Day Low 2.30
Company Name Stock Ticker Symbol Market Type
InVivo Therapeutics Holdings Corporation NVIV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 2.15% 2.38 15:35:55
Open Price Low Price High Price Close Price Prev Close
2.32 2.30 2.41 2.33
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
163 57,457 $ 2.34 $ 134,641 - 0.1953 - 13.7699
Last Trade Time Type Quantity Stock Price Currency
15:41:44 5 $ 2.3412 USD

Period:

Draw Mode:

InVivo Therapeutics Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.56M 1.91M 1.91M $ - $ - -7.39 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 116.20k 49.70%

more financials information »

InVivo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NVIV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.412.482.272.3435,086-0.03-1.24%
1 Month2.402.802.182.4259,207-0.02-0.83%
3 Months2.313.061.612.2490,1890.073.03%
6 Months8.1610.47991.614.11146,613-5.78-70.83%
1 Year0.363513.76990.19534.93344,6242.02554.75%
3 Years0.2213.76990.19531.451,080,2622.16981.82%
5 Years13.5024.500.1191.92777,726-11.12-82.37%

InVivo Therapeutics Description

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.